5 key vendors in the global stem cell therapy market

Biologics

The global stem cell therapy market is projected to grow at a compound annual growth rate of 36.52 percent between 2017 and 2021, according to an analysis by Wise Guy Reports.

The market is propelled forward by an increase in federal funding for stem cell therapy. Here are five key vendors.

 

1. Holostem Advanced Therapies

 

2. JCR Pharmaceuticals

 

3. Organogenesis

 

4. Osiris Therapeutics

 

5. Vericel

 

More articles on biologics:

Cerapedics receives FDA IDE approval for study of P-15L Bone Graft in TLIF surgery: 4 things to know

Drs. Kevin Pauza, Gregory Lutz launch study into non-invasive degenerated disc treatment: 5 highlights

4 things to know about mensenchymal stromal cells in spine

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers